Likmeta M, Shkoza A, Zguri L, Kraja B. CHRONIC HEPATITIS C WITH SIGNIFICANT MORBIDITY AND END-ORGAN DAMAGE DEVELOPMENT DURING PEG-INTERFERON ALPHA-2A/RIBAVIRIN THERAPY. ESJ [Internet]. 2015Jun.29 [cited 2024Nov.22];11(18). Available from: https://eujournal.org/index.php/esj/article/view/5824